Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma

<div>Disease monitoring through CSF IL-10 of two newly diagnosed PCNSL patients without baseline cfDNA. (a) Patient two and (b) patient ten.</div>

Journal of Oncology

fig5

Figure 5

Figure 5: Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma 

Figure 5 | Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma 